Literature DB >> 33781566

c-Kit expression in smooth muscle cells reduces atherosclerosis burden in hyperlipidemic mice.

Zachary M Zigmond1, Lei Song1, Laisel Martinez2, Roberta M Lassance-Soares2, Omaida C Velazquez2, Roberto I Vazquez-Padron3.   

Abstract

BACKGROUND AND AIMS: Increased receptor tyrosine kinase (RTK) activity has been historically linked to atherosclerosis. Paradoxically, we recently found that global deficiency in c-Kit function increased atherosclerosis in hyperlipidemic mice. This study aimed to investigate if such unusual atheroprotective phenotype depends upon c-Kit's function in smooth muscle cells (SMC).
METHODS: We studied atherosclerosis in a SMC-specific conditional knockout mice (KitSMC) and control littermate. Tamoxifen (TAM) and vehicle treated mice were fed high fat diet for 16 weeks before atherosclerosis assessment in the whole aorta using oil red staining. Smooth muscle cells were traced within the aortic sinus of conditional c-Kit tracing mice (KitSMC eYFP) and their control littermates (KitWT eYFP) by immunofluorescent confocal microscopy. We then performed RNA sequencing on primary SMC from c-Kit deficient and control mice, and identified significantly altered genes and pathways as a result of c-Kit deficiency in SMC.
RESULTS: Atherosclerosis significantly increased in KitSMC mice with respect to control groups. In addition, the loss of c-Kit in SMC increased plaque size and necrotic core area in the aortic sinus of hyperlipidemic mice. Smooth muscle cells from KitSMC eYFP mice were more prone to migrate and express foam cell markers (e.g., Mac2 and MCAM) than those from control littermate animals. RNAseq analysis showed a significant upregulation in genes associated with cell proliferation, migration, lipid metabolism, and inflammation secondary to the loss of Kit function in primary SMCs.
CONCLUSIONS: Loss of c-Kit increases SMC migration, proliferation, and expression of foam cell markers in atherosclerotic plaques from hyperlipidemic mice. Published by Elsevier B.V.

Entities:  

Keywords:  Atheroprotective; Atherosclerosis; Foam cell; Receptor tyrosine kinase; Smooth muscle cells; c-Kit

Mesh:

Year:  2021        PMID: 33781566      PMCID: PMC8096668          DOI: 10.1016/j.atherosclerosis.2021.03.004

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  57 in total

1.  Origin of neointimal smooth muscle: we've come full circle.

Authors:  Mark H Hoofnagle; James A Thomas; Brian R Wamhoff; Gary K Owens
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-12       Impact factor: 8.311

2.  A randomized, double-blind, placebo-controlled trial on restenosis prevention by the receptor tyrosine kinase inhibitor imatinib.

Authors:  Dietlind Zohlnhöfer; Jörg Hausleiter; Adnan Kastrati; Julinda Mehilli; Christoph Goos; Helmut Schühlen; Jürgen Pache; Gisela Pogatsa-Murray; Uwe Heemann; Josef Dirschinger; Albert Schömig
Journal:  J Am Coll Cardiol       Date:  2005-11-04       Impact factor: 24.094

Review 3.  Smooth muscle cell signal transduction: implications of vascular biology for vascular surgeons.

Authors:  Akihito Muto; Tamara N Fitzgerald; Jose M Pimiento; Stephen P Maloney; Desarom Teso; Jacek J Paszkowiak; Tormod S Westvik; Fabio A Kudo; Toshiya Nishibe; Alan Dardik
Journal:  J Vasc Surg       Date:  2007-06       Impact factor: 4.268

4.  Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Authors:  Emelia J Benjamin; Paul Muntner; Alvaro Alonso; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Sandeep R Das; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Lori Chaffin Jordan; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Martin O'Flaherty; Ambarish Pandey; Amanda M Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Connie W Tsao; Mintu P Turakhia; Lisa B VanWagner; John T Wilkins; Sally S Wong; Salim S Virani
Journal:  Circulation       Date:  2019-03-05       Impact factor: 29.690

5.  Deficiency of Monoacylglycerol Lipase Enhances IgM Plasma Levels and Limits Atherogenesis in a CB2-Dependent Manner.

Authors:  Raquel Guillamat Prats; Martina Rami; Larisa Ring; Petteri Rinne; Estelle Lauer; Sebastien Lenglet; Aurelien Thomas; Sabrina Pagano; Nicolas Vuilleumier; Benjamin F Cravatt; Christian Weber; Alexander Faussner; Sabine Steffens
Journal:  Thromb Haemost       Date:  2019-01-04       Impact factor: 5.249

6.  Stem cell factor deficiency is vasculoprotective: unraveling a new therapeutic potential of imatinib mesylate.

Authors:  Chao-Hung Wang; Nicole Anderson; Shu-Hong Li; Paul E Szmitko; Wen-Jing Cherng; Paul W M Fedak; Shafie Fazel; Ren-Ke Li; Terrence M Yau; Richard D Weisel; William L Stanford; Subodh Verma
Journal:  Circ Res       Date:  2006-08-24       Impact factor: 17.367

7.  Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis.

Authors:  R Dewberry; H Holden; D Crossman; S Francis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-11       Impact factor: 8.311

8.  Smooth muscle cells in atherosclerosis originate from the local vessel wall and not circulating progenitor cells in ApoE knockout mice.

Authors:  Jacob F Bentzon; Charlotte Weile; Claus S Sondergaard; Johnny Hindkjaer; Moustapha Kassem; Erling Falk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-09-28       Impact factor: 8.311

9.  G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension.

Authors:  Angela Wirth; Zoltán Benyó; Martina Lukasova; Barbara Leutgeb; Nina Wettschureck; Stefan Gorbey; Petra Orsy; Béla Horváth; Christiane Maser-Gluth; Erich Greiner; Björn Lemmer; Günther Schütz; J Silvio Gutkind; Stefan Offermanns
Journal:  Nat Med       Date:  2007-12-16       Impact factor: 53.440

10.  Mast cells promote atherosclerosis by releasing proinflammatory cytokines.

Authors:  Jiusong Sun; Galina K Sukhova; Paul J Wolters; Min Yang; Shiro Kitamoto; Peter Libby; Lindsey A MacFarlane; Jon Mallen-St Clair; Guo-Ping Shi
Journal:  Nat Med       Date:  2007-06-03       Impact factor: 53.440

View more
  1 in total

1.  Dihydromyricetin ameliorates osteogenic differentiation of human aortic valve interstitial cells by targeting c-KIT/interleukin-6 signaling pathway.

Authors:  Shaoshao Zhang; Leilei Fan; Yongjun Wang; Jianjun Xu; Qiang Shen; Jianhua Xie; Zhipeng Zeng; Tingwen Zhou
Journal:  Front Pharmacol       Date:  2022-08-08       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.